1Ministry of Health (2011) Mortality and Demographic Data 2008. Wellington: Ministry of Health.
2Tobias M, Sexton K, Mann S, et al. (2006) How low can it go? Projecting ischaemic heart disease mortality in New Zealand to 2015. N Z Med J 119, U1932.
3Tobias M, Taylor R, Yeh L-C, et al. (2008) Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand. Aust N Z J Public Health 32, 117–125.
4University of Otago and Ministry of Health (2011) A Focus on Nutrition: Key Findings of the 2008/09 New Zealand Adult Nutrition Survey. Wellington: Ministry of Health.
5Badimon L, Vilahur G & Padro T (2010) Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther 28, 202–215.
6Voutilainen S, Nurmi T, Mursu J, et al. (2006) Carotenoids and cardiovascular health. Am J Clin Nutr 83, 1265–1271.
7World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. WHO Technical Report Series no. 916. Geneva: WHO.
8Brown L, Rosner B, Willett WW, et al. (1999) Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30–42.
9Erkkila AT & Lichtenstein AH (2006) Fiber and cardiovascular disease risk: how strong is the evidence? J Cardiovasc Nurs 21, 3–8.
10Salas-Salvado J, Bullo M, Perez-Heras A, et al. (2006) Dietary fibre, nuts and cardiovascular diseases. Br J Nutr 96, S46–S51.
11Schakel S, Pettit J & Himes H (2001) Dietary fiber values for common foods. In The CRC Handbook of Dietary Fiber in Human Nutrition, 3rd ed. [Spiller G, editor]. London: CRC Press.
12Ferguson AR & Ferguson LR (2003) Are kiwifruit really good for you? Acta Hortic 610, 131–135.
13Vissers MCM, Bozonet SM, Pearson JF, et al. (2011) Dietary ascorbate intake affects steady state tissue concentrations in vitamin C-deficient mice: tissue deficiency after suboptimal intake and superior bioavailability from a food source (kiwifruit). Am J Clin Nutr 93, 292–301.
14Hunter DC, Greenwood J, Zhang J, et al. (2011) Antioxidant and ‘natural protective’ properties of kiwifruit. Curr Top Med Chem 11, 1811–1820.
15Tarascou I, Souquet JM, Mazauric JP, et al. (2010) The hidden face of food phenolic composition. Arch Biochem Biophys 501, 16–22.
16Chang WH & Liu JF (2009) Effects of kiwifruit consumption on serum lipid profiles and antioxidative status in hyperlipidemic subjects. Int J Food Sci Nutr 60, 709–716.
17Duttaroy AK & Jorgensen A (2004) Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers. Platelets 15, 287–292.
18Karlsen A, Svendsen M & Seljeflot I, et al. (2012) Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers J Hum Hypertens
19Elder SJ, Lichtenstein AH, Pittas AG, et al. (2009) Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome. J Lipid Res 50, 1917–1926.
20Corella D & Ordovas JM (2005) Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 25, 341–390.
21Masson LF, McNeill G & Avenell A (2003) Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 77, 1098–1111.
22Song Y, Stampfer MJ & Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141, 137–147.
23Jofre-Monseny L, Minihane AM & Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131–145.
24Bennet AM, Di Angelantonio E, Ye Z, et al. (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298, 1300–1311.
25Rimbach G & Minihane AM (2009) Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? Proc Nutr Soc 68, 162–172.
26de Sauvage Nolting PR, Buirma RJ, Hutten BA, et al. (2002) Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia. The examination of probands and relatives in Statin studies with familial hypercholesterolemia. Atherosclerosis 164, 347–354.
27Gould AL, Davies GM, Alemao E, et al. (2007) Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther 29, 778–794.
29Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
30Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495.
31Hixson JE & Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545–548.
32Hall MB, Hoover WH, Jennings JP, et al. (1999) A method for partitioning neutral detergent-soluble carbohydrates. J Sci Food Agric 79, 2079–2086.
33Lee H & Coates G (1987) Liquid chromatographic determination of vitamin C in commercial Florida citrus juice. J Micronutr Anal 3, 199–209.
34Lee R & Nieman D (2010) Nutritional Assessment, 5th ed.New York, NY: McGraw-Hill.
35World Health Organization (1995) Physical Status: The Use and Interpretation of Anthropometry. World Health Organization Technical Report Series no. 854. Geneva: WHO.
36Gordon DJ, Probstfield JL, Garrison RJ, et al. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8–15.
37Turner RC, Millns H, Neil HA, et al. (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316, 823–828.
38Basu A, Rhone M & Lyons TJ (2010) Berries: emerging impact on cardiovascular health. Nutr Rev 68, 168–177.
39Erlund I, Koli R, Alfthan G, et al. (2008) Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 87, 323–331.
40Kurowska EM, Spence JD, Jordan J, et al. (2000) HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72, 1095–1100.
41Albers AR, Varghese S, Vitseva O, et al. (2004) The antiinflammatory effects of purple grape juice consumption in subjects with stable coronary artery disease. Arterioscler Thromb Vasc Biol 24, e179–e180.
42Ruel G, Pomerleau S, Couture P, et al. (2006) Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr 96, 357–364.
43Khan N, Monagas M & Andres-Lacueva C, et al. (2011) Regular consumption of cocoa powder with milk increases HDL-cholesterol and reduces oxidized LDL levels in subjects at high-risk of cardiovascular disease Nutr Metab Cardiovasc Dis
44Mellor DD, Sathyapalan T, Kilpatrick ES, et al. (2010) High-cocoa polyphenol-rich chocolate improves HDL-cholesterol in Type 2 diabetes patients. Diabet Med 27, 1318–1321.
45Yasuda A, Natsume M, Osakabe N, et al. (2011) Cacao polyphenols influence the regulation of apolipoprotein in HepG2 and Caco2 cells. J Agric Food Chem 59, 1470–1476.
46Lamarche B, Rashid S & Lewis GF (1999) HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 286, 145–161.
47Miller M, Langenberg P & Havas S (2007) Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects. Int J Cardiol 119, 192–195.
48Brevik A, Gaivao I, Medin T, et al. (2011) Supplementation of a western diet with golden kiwifruits (Actinidia chinensis var.‘Hort 16A’:) effects on biomarkers of oxidation damage and antioxidant protection. Nutr J 10, 54.
49Zaiden N, Yap WN, Ong S, et al. (2010) Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion. J Atheroscler Thromb 17, 1019–1032.
50Shen Y-C, Chen S-L & Wang C-K (2007) Contribution of tomato phenolics to antioxidation and down-regulation of blood lipids. J Agric Food Chem 55, 6475–6481.
51Gorinstein S, Caspi A, Libman I, et al. (2006) Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans. J Agric Food Chem 54, 1887–1892.
52Caslake MJ, Miles EA, Kofler BM, et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 88, 618–629.
53Corbo RM & Scacchi R (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Ann Hum Genet 63, 301–310.
54Gerdes LU (2003) The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin Chem Lab Med 41, 628–631.
55Huebbe P, Nebel A, Siegert S, et al. (2011) APOE epsilon4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 25, 3262–3270.
56National Cholesterol Education Program (NCEP) Expert Panel (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421.